Top 11 Fastest-Growing Generics Companies #world-pharma.org

Posted On May 31 2017 by

#generic pharma companies # Top 11 Fastest-Growing Generics Companies For generics makers, Big Pharma’s patent cliff is more like a mountain. With preparation and drive and some luck, companies that specialize in copycat drugs can climb from one newly off-patent blockbuster to another, adding millions in sales along the way. Sometimes many millions: Ranbaxy Laboratories reportedly reaped $500 million in sales from its knockoff of Pfizer’s ($PFE) cholesterol pill Lipitor during its first 6 months on the market. Plus, branded drugmakers have been diversifying to make up for plummeting sales of their no-longer-exclusive megadrugs. Sometimes, that means joining hands with …


Saneca-owned generics firm Suir Pharma will sack 130 staff says liquidator #pharma #kava

Posted On May 18 2017 by

#outsourcing pharma # Saneca-owned generics firm Suir Pharma will sack 130 staff says liquidator By Gareth MacDonald+ Gareth MACDONALD 18-May-2016 2016-05-18T00:00:00Z Last updated on 18-May-2016 at 17:00 GMT 2016-05-18T17:00:29Z Suir Pharma is set to close or be sold with the loss of 130 jobs less than a year after it was acquired by Slovakian API manufacturer Saneca Pharmaceuticals. The Irish High Court appointed Michael McAteer from Grant Thornton as Suir’s liquidator on Tuesday, tasking him with either finding a buyer for the generic drug manufacturer or with helping it wind up its operations. A Grant Thornton spokesman told us the …


Top 11 Fastest-Growing Generics Companies #chicago #pharmaceutical #companies

Posted On Apr 30 2017 by

#generic pharma companies # Top 11 Fastest-Growing Generics Companies For generics makers, Big Pharma’s patent cliff is more like a mountain. With preparation and drive and some luck, companies that specialize in copycat drugs can climb from one newly off-patent blockbuster to another, adding millions in sales along the way. Sometimes many millions: Ranbaxy Laboratories reportedly reaped $500 million in sales from its knockoff of Pfizer’s ($PFE) cholesterol pill Lipitor during its first 6 months on the market. Plus, branded drugmakers have been diversifying to make up for plummeting sales of their no-longer-exclusive megadrugs. Sometimes, that means joining hands with …


Top 11 Fastest-Growing Generics Companies #northern #pharma

Posted On Apr 21 2017 by

#generic pharma companies # Top 11 Fastest-Growing Generics Companies For generics makers, Big Pharma’s patent cliff is more like a mountain. With preparation and drive and some luck, companies that specialize in copycat drugs can climb from one newly off-patent blockbuster to another, adding millions in sales along the way. Sometimes many millions: Ranbaxy Laboratories reportedly reaped $500 million in sales from its knockoff of Pfizer’s ($PFE) cholesterol pill Lipitor during its first 6 months on the market. Plus, branded drugmakers have been diversifying to make up for plummeting sales of their no-longer-exclusive megadrugs. Sometimes, that means joining hands with …


Teva Pharma (TEVA) Announces Completion of Actavis Generics (AGN) Acquisition #pharma #pro

Posted On Apr 15 2017 by

#actavis pharma # Teva Pharma (TEVA) Announces Completion of Actavis Generics (AGN) Acquisition August 2, 2016 1:15 PM Teva Pharmaceutical Industries Ltd. (NYSE: TEVA ) and Allergan plc (NYSE: AGN ) today announced that Teva has completed its acquisition of Allergan’s generics business (“Actavis Generics”). This strategic acquisition brings together two leading generics businesses with complementary strengths, R Teva will have a pipeline capable of over 5000 launches across the region. In Teva growth markets including, Asia, Africa, Latin America, Middle East, Russia and CIS, there are now approximately 600 pending product approvals. Overall, Teva is planning for 1,500 generic …


Top 20 generics companies by 2014 revenue #dishman #pharma

Posted On Apr 11 2017 by

#generic drug companies # Top 20 generics companies by 2014 revenue To most of the world, the term “generic” suggests something everyday, common or bland, but to the drug industry generic is anything but bland. It represents a high-volume, low-margin business that is certainly not for sissies. It calls for scientific and manufacturing skills, a superb sales operation, and fortitude. It comes with risks but also has plenty of rewards. In the U.S. the largest drug market in the world, generic drugs account for 80% of the prescriptions written. According to data from the market intelligence miners at EvaluatePharma. worldwide …


Top 11 Fastest-Growing Generics Companies #pharmaceutical #sector

Posted On Feb 13 2017 by

#generic pharma companies # Top 11 Fastest-Growing Generics Companies For generics makers, Big Pharma’s patent cliff is more like a mountain. With preparation and drive and some luck, companies that specialize in copycat drugs can climb from one newly off-patent blockbuster to another, adding millions in sales along the way. Sometimes many millions: Ranbaxy Laboratories reportedly reaped $500 million in sales from its knockoff of Pfizer’s ($PFE) cholesterol pill Lipitor during its first 6 months on the market. Plus, branded drugmakers have been diversifying to make up for plummeting sales of their no-longer-exclusive megadrugs. Sometimes, that means joining hands with …


Top 11 Fastest-Growing Generics Companies #pharmaceutical #industry #research

Posted On Feb 2 2017 by

#generic pharma companies # Top 11 Fastest-Growing Generics Companies For generics makers, Big Pharma’s patent cliff is more like a mountain. With preparation and drive and some luck, companies that specialize in copycat drugs can climb from one newly off-patent blockbuster to another, adding millions in sales along the way. Sometimes many millions: Ranbaxy Laboratories reportedly reaped $500 million in sales from its knockoff of Pfizer’s ($PFE) cholesterol pill Lipitor during its first 6 months on the market. Plus, branded drugmakers have been diversifying to make up for plummeting sales of their no-longer-exclusive megadrugs. Sometimes, that means joining hands with …


Saneca-owned generics firm Suir Pharma will sack 130 staff says liquidator #bi #pharma

Posted On Jan 9 2017 by

#outsourcing pharma # Saneca-owned generics firm Suir Pharma will sack 130 staff says liquidator By Gareth MacDonald+ Gareth MACDONALD 18-May-2016 2016-05-18T00:00:00Z Last updated on 18-May-2016 at 17:00 GMT 2016-05-18T17:00:29Z Suir Pharma is set to close or be sold with the loss of 130 jobs less than a year after it was acquired by Slovakian API manufacturer Saneca Pharmaceuticals. The Irish High Court appointed Michael McAteer from Grant Thornton as Suir’s liquidator on Tuesday, tasking him with either finding a buyer for the generic drug manufacturer or with helping it wind up its operations. A Grant Thornton spokesman told us the …


Top 11 Fastest-Growing Generics Companies #pharma #dictionary

Posted On Dec 20 2016 by

#generic pharma companies # Top 11 Fastest-Growing Generics Companies For generics makers, Big Pharma’s patent cliff is more like a mountain. With preparation and drive and some luck, companies that specialize in copycat drugs can climb from one newly off-patent blockbuster to another, adding millions in sales along the way. Sometimes many millions: Ranbaxy Laboratories reportedly reaped $500 million in sales from its knockoff of Pfizer’s ($PFE) cholesterol pill Lipitor during its first 6 months on the market. Plus, branded drugmakers have been diversifying to make up for plummeting sales of their no-longer-exclusive megadrugs. Sometimes, that means joining hands with …